A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza (NCT07159763)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, when given as a single dose via 3 subcutaneous (SQ) injections to adult and adolescent participants who are at higher risk of developing influenza complications, and to evaluate the safety and tolerability of CD388, as compared to placebo.
Who can join: Review the eligibility criteria below.
Location: Pinnacle Research Group, LLC — Anniston, Alabama
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (181 Sites)
Showing the first 25 of 181 sites.
- Pinnacle Research Group, LLC — Anniston, Alabama
- Cullman Clinical Trials — Cullman, Alabama
- HOPE Research Institute — Glendale, Arizona
- Desert Clinical Research, LLC / Avacare — Mesa, Arizona
- Foothills Research Center / Avacare — Phoenix, Arizona
- Fiel Family and Sports Medicine / Avacare — Tempe, Arizona
- HOPE Research Institute — Tempe, Arizona
- Arizona Clinical Trials — Tucson, Arizona
- Del Sol Research Management, LLC — Tucson, Arizona
- Triallogix Medical Corporation — Fullerton, California
- National Institute of Clinical Research, Inc. — Garden Grove, California
- Eximia Research-CA, LLC — La Mesa, California
- Kinetic Clinical Research, LLC dba Long Beach Clinical Trials — Long Beach, California
- Seaside Medical Group — Oceanside, California
- Profound Research, LLC — Pasadena, California
- Paradigm Clinical Research — Redding, California
- Artemis Institute for Clinical Research — San Diego, California
- Acclaim Clinical Research — San Diego, California
- Diablo Clinical Research, Inc. — Walnut Creek, California
- Tekton Research, LLC — Denver, Colorado
- Tekton Research, LLC — Fort Collins, Colorado
- Critical Care, Pulmonary and Sleep Associates PLLP / Avacare — Lakewood, Colorado
- Tekton Research, LLC — Longmont, Colorado
- New England Research Associates — Bridgeport, Connecticut
- Stamford Therapeutics Consortium — Stamford, Connecticut
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Influenza
- Kaiser Colorado Flu Nudge — Aurora, Colorado
- Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine — Halifax, Nova Scotia
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults — Birmingham, Alabama
- Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants — Cincinnati, Ohio
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults — San Bernardino, California
Explore by condition: All Influenza clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.